in

Stock market live updates: Dow up 200, Boeing driving gains, Facebook falls on boycott

The New York Stock Exchange (NYSE) stands in lower Manhattan on the first day that traders are allowed back onto the historic floor of the exchange on May 26, 2020 in New York City.

Spencer Platt | Getty Images

This is a live blog. Please check back for updates.

9:31 am: Stocks start the week in the green, Dow up 200 points

U.S. equities started the week on a strong foot with all three major averages registering gains. The Dow Jones Industrial Average rose 206 points, helped by a 6% jump in Boeing. The S&P 500 rose 0.55% and the Nasdaq jumped 0.25%. — Fitzgerald 

9:21 am: Beyond Meat falls after double downgrade from Barclays

Shares of Beyond Meat sank more than 4% in premarket trading after Barclays downgraded the stock by two notches, to underweight from overweight. CNBC Pro subscribers can read more about the mover here. —Pound

9:00 am: Credit Suisse downgrades theaters as cases rise

Analysts at Credit Suisse downgraded movie theater chains after rising cases of the coronavirus led some areas to pause or roll back reopening plans and led to further delays in major summer film releases. The firm downgraded AMC Entertainment to underperform from neutral, slashing its price target in half to $2 per share, and Cinemark Holdings to neutral from outperform. Credit Suisse’s new target for Cinemark is $13 per share, down from $20. Shares of AMC dropped more than 7% in premarket trading, while Cinemark fell 3.1%. —Pound

8:45 am: Facebook shares under pressure as more advertisers join boycott

Facebook’s stock fell more than 3% in premarket trading Monday as more companies said they will pause advertising on its platforms. Since Friday, Starbucks, Coca Cola and Guinness-parent Diageo all announced they will halt advertising on social media. The move is seen as part of a broader effort among a growing number of companies to force social media platforms to crack down on hate speech and disinformation on their platforms. For its part, Starbucks said in a press statement that it believes “in bringing communities together, both in person and online, and we stand against hate speech.” — Franck

8:42 am: Gilead shares jump after it sets prices for coronavirus treatment

Gilead Sciences said it would start charging for its coronavirus treatment remdesivir, sending shares up nearly 3% in premarket trading. The Foster City, California-based drugmaker estimated the cost at $3,120 for a typical U.S. patient with commercial insurance. The price for governments in developed countries will be $390 per vial, while private U.S. insurers will pay $520, meaning that Medicare patients will pay less than those with private insurance. The typical treatment is a five-day course entailing six vials, the company said. – Cox

8:23 am: Coronavirus cases continue to rise as more areas restrict movements

Coronavirus cases rose by 85,632 over the weekend amid a continued surge in hotspots in the South and West. That rise represented a 3.5% increase from Friday to Sunday, according to the Covid Tracking Project. Deaths, which are a lagging indicator, grew by 779 to 119,429, or 0.7%. In response to the increase in cases, a number of governors and local officials have begun reimposing restrictions. Texas has shut down bars and some Florida beaches are closing as well. Florida saw 18,115 new cases over the weekend, a 14.7% surge, though hospitalizations increased just 1.8%. Arizona, another trouble area, saw another 7,360 cases in the two-day period, up 11%, while hospitalizations rose 2.2%. – Cox

8:19 am: Shares of Coty surge nearly 20% on Kardashian 

Shares of cosmetic company Coty jumped 18% in premarket trading on Monday following news that the company will buy a 20% stake in Kim Kardashian West’s makeup brand. Coty had said earlier this month that it was talking to Kardashian West about a possible collaboration. Coty will pay $200 million for the partial ownership. This is Coty’s second deal with the Kardashian/Jenner family this year, having already taken a 51% stake in Kylie Jenner’s brands. — Fitzgerald 

8:09 am: Boeing soars ahead of test flights

Shares of Boeing jumped 7.7% as the aerospace giant gets set for re-certification flights of the 737 Max, which has been grounded by regulators for more than a year following two fatal crashes. The flights are scheduled to begin Monday and will gather data for regulators to examine whether the fixes made to the plane are sufficient for it to return to commercial fleets. —Pound

8:02 am: Southwest jumps on Goldman upgrade

Goldman upgraded shares of Southwest on Monday to buy from sell and raised its 12-month price target to $47 per sahre from $35 per share, sending shares of the airline up nearly 4% in premarket trading. The firm said the airline industry is managing its cash burn better-than-expected and likes Southwest for its domestic focus. “We expect its primarily domestic network and industry-leading balance sheet to drive a relatively faster and stronger recovery from the COVID-19-driven downturn in demand for air travel,” Goldman said in a note. Goldman also said a resurgence in coronavirus cases is not helping the recovery of the ailing industry. — Fitzgerald

7:40 am: Stock futures rise despite a surge in U.S. coronavirus cases

Stock futures were higher in morning trading on Monday even as coronavirus cases in the U.S. continued to surge. The Dow Jones Industrial Average futures climbed about 140 points, indicating an opening gain of about 200 points. S&P 500 futures gained 0.3%. Nasdaq-100 futures were slightly lower. The moves in futures market followed a week of sharp losses as the recent spike in virus cases raised concerns about the pace of the economic recovery. The Dow and the S&P 500 were on pace to post their first monthly decline in three. — Li

— with reporting from CNBC’s Jeff Cox. 

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.

Source: Finance - cnbc.com

Lawmakers worry debit-card stimulus payments come with high fees, compromise personal information

Gilead's coronavirus treatment remdesivir to cost $3,120 per U.S. patient with private insurance